Your search returned 34 results.

Results
	21.	Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. [electronic resource] by Mileshkin, Linda Hicks, Rodney J Hughes, Brett G M Mitchell, Paul L R Charu, Veena Gitlitz, Barbara J Macfarlane, David Solomon, Benjamin Amler, Lukas C Yu, Wei Pirzkall, Andrea Fine, Bernard M Producer: 20111007 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium. [electronic resource] by Campbell, Nicholas P Kunnavakkam, Rangesh Leighl, Natasha Vincent, Mark D Gandara, David R Koczywas, Marianna Gitlitz, Barbara J Agamah, Edem Thomas, Sachdev P Stadler, Walter M Vokes, Everett E Kindler, Hedy L Producer: 20130123 In: Lung cancer (Amsterdam, Netherlands) vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial. [electronic resource] by Gitlitz, Barbara J Tsao-Wei, Denice D Groshen, Susan Davies, Angela Koczywas, Marianna Belani, Chandra P Argiris, Athanassios Ramalingam, Suresh Vokes, Everett E Edelman, Martin Hoffman, Philip Ballas, Marc S Liu, Stephen V Gandara, David R Producer: 20120614 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ( [electronic resource] by Reckamp, Karen L Frankel, Paul H Ruel, Nora Mack, Philip C Gitlitz, Barbara J Li, Tianhong Koczywas, Marianna Gadgeel, Shirish M Cristea, Mihaela C Belani, Chandra P Newman, Edward M Gandara, David R Lara, Primo N Publication details: Frontiers in oncology 2019 In: Frontiers in oncology vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors. [electronic resource] by Daud, Adil I Krishnamurthi, Smitha S Saleh, Mansoor N Gitlitz, Barbara J Borad, Mitesh J Gold, Philip J Chiorean, Elena G Springett, Gregory M Abbas, Richat Agarwal, Shefali Bardy-Bouxin, Nathalie Hsyu, Poe-Hirr Leip, Eric Turnbull, Kathleen Zacharchuk, Charles Messersmith, Wells A Producer: 20120613 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors. [electronic resource] by Liu, Stephen V Groshen, Susan G Kelly, Karen Reckamp, Karen L Belani, Chandra Synold, Timothy W Goldkorn, Amir Gitlitz, Barbara J Cristea, Mihaela C Gong, I-Yeh Semrad, Thomas J Xu, Yucheng Xu, Tong Koczywas, Marianna Gandara, David R Newman, Edward M Producer: 20190729 In: Cancer chemotherapy and pharmacology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. [electronic resource] by Ou, Sai-Hong Ignatius Schrock, Alexa B Bocharov, Eduard V Klempner, Samuel J Haddad, Carolina Kawamura Steinecker, Gary Johnson, Melissa Gitlitz, Barbara J Chung, Jon Campregher, Paulo V Ross, Jeffrey S Stephens, Philip J Miller, Vincent A Suh, James H Ali, Siraj M Velcheti, Vamsidhar Producer: 20171121 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. [electronic resource] by Chao, Joseph Synold, Timothy W Morgan, Robert J Kunos, Charles Longmate, Jeff Lenz, Heinz-Josef Lim, Dean Shibata, Stephen Chung, Vincent Stoller, Ronald G Belani, Chandra P Gandara, David R McNamara, Mark Gitlitz, Barbara J Lau, Derick H Ramalingam, Suresh S Davies, Angela Espinoza-Delgado, Igor Newman, Edward M Yen, Yun Producer: 20120420 In: Cancer chemotherapy and pharmacology vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study. [electronic resource] by Horn, Leora Infante, Jeffrey R Reckamp, Karen L Blumenschein, George R Leal, Ticiana A Waqar, Saiama N Gitlitz, Barbara J Sanborn, Rachel E Whisenant, Jennifer G Du, Liping Neal, Joel W Gockerman, Jon P Dukart, Gary Harrow, Kimberly Liang, Chris Gibbons, James J Holzhausen, Allison Lovly, Christine M Wakelee, Heather A Producer: 20191119 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	30.	EGFR Fusions as Novel Therapeutic Targets in Lung Cancer. [electronic resource] by Konduri, Kartik Gallant, Jean-Nicolas Chae, Young Kwang Giles, Francis J Gitlitz, Barbara J Gowen, Kyle Ichihara, Eiki Owonikoko, Taofeek K Peddareddigari, Vijay Ramalingam, Suresh S Reddy, Satyanarayan K Eaby-Sandy, Beth Vavalà, Tiziana Whiteley, Andrew Chen, Heidi Yan, Yingjun Sheehan, Jonathan H Meiler, Jens Morosini, Deborah Ross, Jeffrey S Stephens, Philip J Miller, Vincent A Ali, Siraj M Lovly, Christine M Producer: 20170411 In: Cancer discovery vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	31.	Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial. [electronic resource] by Ferris, Robert L Saba, Nabil F Gitlitz, Barbara J Haddad, Robert Sukari, Ammar Neupane, Prakash Morris, John C Misiukiewicz, Krzysztof Bauman, Julie E Fenton, Moon Jimeno, Antonio Adkins, Douglas R Schneider, Charles J Sacco, Assuntina G Shirai, Keisuke Bowles, Daniel W Gibson, Michael Nwizu, Tobenna Gottardo, Raphael Manjarrez, Kristi L Dietsch, Gregory N Bryan, James Kyle Hershberg, Robert M Cohen, Ezra E W Producer: 20191009 In: JAMA oncology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	32.	Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742). [electronic resource] by Ma, Brigette B Y Lim, Wan-Teck Goh, Boon-Cher Hui, Edwin P Lo, Kwok-Wai Pettinger, Adam Foster, Nathan R Riess, Jonathan W Agulnik, Mark Chang, Alex Y C Chopra, Akhil Kish, Julie A Chung, Christine H Adkins, Douglas R Cullen, Kevin J Gitlitz, Barbara J Lim, Dean W To, Ka-Fai Chan, K C Allen Lo, Y M Dennis King, Ann D Erlichman, Charles Yin, Jun Costello, Brian A Chan, Anthony T C Producer: 20190726 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	33.	Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. [electronic resource] by Vannini, Ivan Wise, Petra M Challagundla, Kishore B Plousiou, Meropi Raffini, Mirco Bandini, Erika Fanini, Francesca Paliaga, Giorgia Crawford, Melissa Ferracin, Manuela Ivan, Cristina Fabris, Linda Davuluri, Ramana V Guo, Zhiyi Cortez, Maria Angelica Zhang, Xinna Chen, Lu Zhang, Shuxing Fernandez-Cymering, Cecilia Han, Leng Carloni, Silvia Salvi, Samanta Ling, Hui Murtadha, Mariam Neviani, Paolo Gitlitz, Barbara J Laird-Offringa, Ite A Nana-Sinkam, Patrick Negrini, Massimo Liang, Han Amadori, Dino Cimmino, Amelia Calin, George A Fabbri, Muller Publication details: Nature communications 01 2018 In: Nature communications vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	34.	Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. [electronic resource] by Vannini, Ivan Wise, Petra M Challagundla, Kishore B Plousiou, Meropi Raffini, Mirco Bandini, Erika Fanini, Francesca Paliaga, Giorgia Crawford, Melissa Ferracin, Manuela Ivan, Cristina Fabris, Linda Davuluri, Ramana V Guo, Zhiyi Cortez, Maria Angelica Zhang, Xinna Chen, Lu Zhang, Shuxing Fernandez-Cymering, Cecilia Han, Leng Carloni, Silvia Salvi, Samanta Ling, Hui Murtadha, Mariam Neviani, Paolo Gitlitz, Barbara J Laird-Offringa, Ite A Nana-Sinkam, Patrick Negrini, Massimo Liang, Han Amadori, Dino Cimmino, Amelia Calin, George A Fabbri, Muller Producer: 20180919 In: Nature communications vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)